Cargando…

Beyond amyloid: New approaches to Alzheimer's disease treatment

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000330/ https://www.ncbi.nlm.nih.gov/pubmed/32007187 http://dx.doi.org/10.1016/j.ebiom.2020.102648

Ejemplares similares

Sleep in Alzheimer's Disease–Beyond Amyloid
por: Holth, Jerrah K., et al.
Publicado: (2016)

Beyond amyloid: altered gene function in neurodegenerative diseases
por: Yesiltepe, Metin, et al.
Publicado: (2023)

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?
por: Loureiro, Julia C., et al.
Publicado: (2022)

Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
por: Castello, Michael A, et al.
Publicado: (2014)

News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
por: Gandy, Sam
Publicado: (2023)

Amyloid PET imaging: applications beyond Alzheimer’s disease
por: Catafau, Ana M., et al.
Publicado: (2015)

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
por: Song, Chenghuan, et al.
Publicado: (2022)

Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions
por: Shi, Jiong, et al.
Publicado: (2020)

New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2014)

New Hopes for Treatment of Alzheimer’s Disease
por: Akhondzadeh, Shahin
Publicado: ( 201)

The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
por: Morelli, Laura, et al.
Publicado: (2012)

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology
por: Giuffrida, Maria Laura
Publicado: (2023)

Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
por: Rayaprolu, Sruti, et al.
Publicado: (2020)

Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease
por: Dawkins, Edgar, et al.
Publicado: (2014)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

Beyond One-Trick Ponies: The Multifunctional Marvels of Microbial Functional Amyloids
por: Landau, Meytal
Publicado: (2023)

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies
por: Tousi, Babak, et al.
Publicado: (2021)

Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions
por: Greenberg, Barry D., et al.
Publicado: (2023)

Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
por: Gomez, Wileidy, et al.
Publicado: (2020)

Impact of apolipoprotein E isoforms on sporadic Alzheimer’s disease: beyond the role of amyloid beta
por: Lozupone, Madia, et al.
Publicado: (2023)

CSF β-amyloid and white matter damage: unravelling the neuropathology of Alzheimer’s disease
por: Sousa Alves, Gilberto
Publicado: (2018)

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo–PrP(C) binding and downstream pathways
por: Grayson, James D., et al.
Publicado: (2021)

New light on the horizon of Alzheimer's disease
por: Poo, Mu-ming
Publicado: (2020)

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Tanaka, Masashi, et al.
Publicado: (2020)

The amyloid precursor protein: beyond amyloid
por: Zheng, Hui, et al.
Publicado: (2006)

Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
por: Buccellato, Francesca R., et al.
Publicado: (2023)

Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
por: Lane, Rachel F, et al.
Publicado: (2011)

Potential Therapeutic Strategies for Alzheimer's Disease Targeting or Beyond β-Amyloid: Insights from Clinical Trials
por: Jia, Qiutian, et al.
Publicado: (2014)

Medical Biotechnology and Alzheimer’s Disease: New Hopes
por: Akhondzadeh, Shahin
Publicado: (2016)

New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
por: Fedele, Ernesto
Publicado: (2023)

Dupilumab Treatment for Asthma: On the Road to a New Horizon Beyond Ethnic Differences?
por: Lee, Yong Won, et al.
Publicado: (2022)

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)

New drug discovery for Alzheimer's disease: Challenges and hopes
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2009)

Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
por: Wu, Tong, et al.
Publicado: (2022)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
por: Hillen, Heinz
Publicado: (2023)

Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
por: Leisher, Solana, et al.
Publicado: (2023)

(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis
por: Fagiani, Francesca, et al.
Publicado: (2021)

Care programme approach – time to move beyond?
por: Kingdon, David
Publicado: (2019)

The Need for Early Detection and Treatment in Alzheimer's Disease
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_15edkutiqpmb8f8nqgpai375ea